|
Diagnosis and Management of Secondary Hemophagocytic Lymphohistiocytosis |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Comprehensive Care for Adult Survivors of Hematologic Malignancies |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Emerging Treatment Options for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
0.75 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Novel Treatment Options for Hodgkin Lymphoma |
0.75 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Optimizing First-Line Therapy for Diffuse Large B-Cell Lymphoma |
0.75 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Evolving Treatment Options for Relapsed/Refractory Follicular Lymphoma |
0.75 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Challenges in Management of Chronic Lymphocytic Leukemia-Richter Transformation |
1.00 |
02/05/2026 - 12:00am to 01/26/2027 - 11:59pm |
|
The Role of Minimal Residual Disease in Hematologic Malignancies |
1.00 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - Hitting the Right Target: Updates in Biomarker-Directed Therapy for Non-Small Cell Lung Cancer |
1.00 |
04/09/2026 - 12:00am to 10/04/2026 - 11:59pm |
|
NCCN Guidelines® Insights - Merkel Cell Carcinoma, Version 1.2024 (JA copy) |
1.00 |
04/01/2026 - 12:00am to 12/31/2026 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - From Mutation to Treatment: Understanding the Impact of New Targeted Therapies in Central Nervous System Cancers |
1.00 |
04/01/2026 - 12:00am to 09/11/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Optimizing Treatment of Chronic Phase Chronic Myeloid Leukemia |
1.00 |
03/09/2026 - 12:00am to 02/24/2027 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations |
1.00 |
02/27/2026 - 12:00am to 08/16/2026 - 11:59pm |
|
NCCN Tumor Boards: Optimizing Clinical Decision-Making for Resectable Non-Small Cell Lung Cancer |
1.00 |
02/13/2026 - 12:00am to 07/26/2026 - 12:00am |
|
NCCN Guidelines® Insights - Soft Tissue Sarcoma, Version 1.2025 |
1.00 |
12/10/2025 - 12:00am to 12/10/2026 - 11:59pm |
Facebook
X
LinkedIn
Forward